Mr. Saglio previously was engaged as the Company’s Chief Financial Officer and has been continuously engaged with the Company since 2011, primarily as a business consultant/advisor. Mr. Saglio holds a BS degree in business administration from the University of Maryland and is a Certified Public Accountant (inactive) in Maryland. Mr. Saglio has over 30 years of corporate finance experience and SEC compliance across a broad range of industries primarily at the senior level. He is experienced in the biotechnology field having previously worked for EntreMed Inc., from 2000 – 2008 including serving as chief financial officer from 2003 – 2008. Mr. Saglio currently advises the Company on financial transactions, SEC regulatory compliance, and accounting matters.